Skip to main content
Clinical Trials/NCT01293110
NCT01293110RecruitingNot Applicable

Database of Patients With Lower Urinary Tract Dysfunction Treated at the University of Zürich

University of Zurich1 site in 1 country7,000 target enrollmentStarted: January 2010Last updated:
Conditions

Trial Snapshot

Phase
Not Applicable
Status
Recruiting
Enrollment
7,000
Locations
1
Primary Endpoint
Survival of the patients

Study Overview

Brief Summary

Patients with neurological disease/injury often suffer from lower urinary tract symptoms, which frequently have a negative impact on the patients' health related quality of life. The prevalence of lower urinary tract dysfunction is high and the treatment is a challenge because available treatments may fail. In this study data of patients with lower urinary tract dysfunction treated at the University of Zürich, are prospectively and systematically collected in a database.

Detailed Description

Lower urinary tract dysfunction is characterized by detrusor overactivity, detrusor sphincter dyssynergia, voiding dysfunction, stress incontinence, or a combination of these and frequently has a negative impact on the patients' health related quality of life. In addition, the treatment of lower urinary tract dysfunction is a challenge because conventional therapies may fail. Adequate treatment and long-term follow-up of lower urinary tract dysfunction is important to achieve/maintain continence and preserve renal function. Thus, we aim to prospectively collect clinical, video-urodynamic and radiological data of patients with neurogenic lower urinary tract dysfunction treated at the University of Zürich in a database.

Study Design

Study Type
Observational
Observational Model
Case Only
Time Perspective
Prospective

Eligibility Criteria

Ages
18 Years to 90 Years (Adult, Older Adult)
Sex
All
Accepts Healthy Volunteers
Yes

Inclusion Criteria

  • •patient of Balgrist University Hospital
  • •patient of University Hospital Zürich
  • •urodynamic examination
  • •written informed consent

Exclusion Criteria

  • •no written informed consent

Outcomes

Primary Outcomes

Survival of the patients

Time Frame: first visit to death

Secondary Outcomes

No secondary outcomes reported

Investigators

Sponsor Class
Other
Responsible Party
Principal Investigator
Principal Investigator

Thomas Kessler

executive physician

Balgrist University Hospital

Study Sites (1)

Loading locations...

Similar Trials